American Shared Hospital Services (AMS) AI Stock Analysis

• Market Cap: $15.48M
• Dividend Yield: N/A
• Average Volume (3M): 15.28K
• Price to Earnings (P/E): 10.9
• Beta (1Y): -0.03
• Revenue Growth: 35.25%
• EPS Growth: 175.21%
• Country: US
• Employees: 81
• Sector: Healthcare
• Sector Strength: 44
• Industry: Medical - Care Facilities
• EPS (TTM): -0.10
• Shares Outstanding: 6,450,000
• 10 Day Avg. Volume: 16,622
• 30 Day Avg. Volume: 15,282
• PEG Ratio: -0.31
• Price to Book (P/B): 0.63
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -2.48
• Enterprise Value/Market Cap: 0.51
• Enterprise Value/Revenue: 0.07
• Enterprise Value/Gross Profit: 1.00
• Enterprise Value/Ebitda: 0.20
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 63 Neutral
• Price Target: $2.50 ▲( 4.60% Upside)

AMS's stock score is driven by strong revenue growth and strategic expansion plans. However, negative free cash flow and bearish technical indicators pose risks. The valuation suggests potential undervaluation, and recent corporate changes could support future growth. Challenges in the Equipment Leasing segment and a net loss impact the overall sentiment.

American Shared Hospital Services Business Overview & Revenue Model

Company Description

American Shared Hospital Services leases radiosurgery and radiation therapy equipment to health care providers. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides financing services for Leksell Gamma Knife units. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers. As of December 31, 2021, it had 115 operating Gamma Knife units located in the United States, as well as two in South America in Lima, Peru and Guayaquil, Ecuador. The company also operates one PBRT system. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.

How the Company Makes Money

AMS makes money through a revenue model that involves leasing advanced medical equipment and providing associated services to hospitals and medical providers. The company generates revenue by entering into long-term contracts with healthcare institutions, where it supplies and maintains sophisticated medical technology such as linear accelerators and gamma knife systems used in radiation therapy. This model allows hospitals to access cutting-edge technology without the significant upfront capital expenditure. AMS also capitalizes on partnerships with major equipment manufacturers and healthcare providers to enhance its service offerings and expand its market reach.

American Shared Hospital Services Financial Statement Overview

Summary

American Shared Hospital Services demonstrates strong revenue growth and a positive net profit margin. The balance sheet is stable with low leverage, but negative free cash flow highlights cash management challenges.

Income Statement

American Shared Hospital Services shows a positive revenue growth trajectory, with TTM revenue increasing to $29.2M from $28.3M annually. Gross profit margins remain healthy, though there is a notable decrease to 27.1% TTM from 32.4% annually. Net profit margin is positive at 4.9% TTM, reflecting improved profitability from a challenging past. The company shows volatility in EBIT, with a negative margin at -10.3% TTM, indicating operational challenges. EBITDA remains strong, highlighting potential operational efficiency.

Balance Sheet

The balance sheet indicates a stable financial position with a debt-to-equity ratio of 0.15 TTM, which is relatively low and manageable. However, stockholder equity decreased substantially, leading to an inflated equity ratio calculation. Return on equity for TTM stands at 5.9%, showcasing moderate efficiency in generating profits from shareholders' investments. Overall, the company's leverage appears well-managed, though equity fluctuations could pose risks.

Cash Flow

Operating cash flow to net income ratio is strong at 3.1 TTM, which indicates efficient cash generation relative to net income. However, the free cash flow is negative, highlighting potential challenges in covering capital expenditures. The free cash flow to net income ratio is also negative, indicating that the company needs to improve its cash flow management to support growth and investment activities.

Breakdown
TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
29.24M	28.34M	21.32M	19.75M	17.63M	17.84M
	Gross Profit
7.92M	9.19M	9.34M	8.38M	6.73M	4.47M
	EBIT
-3.01M	-2.81M	270.00K	-1.46M	-2.78M	-132.00K
	EBITDA
7.87M	8.91M	6.97M	8.44M	6.97M	-1.14M
	Net Income Common Stockholders
1.44M	2.19M	610.00K	1.33M	678.00K	-7.72M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
11.24M	11.03M	13.69M	12.45M	8.26M	3.96M
	Total Assets
63.31M	60.20M	48.16M	43.96M	45.43M	43.65M
	Total Debt
3.67M	23.23M	15.68M	14.31M	16.13M	14.40M
	Net Debt
-7.57M	12.20M	1.87M	1.86M	7.87M	10.44M
	Total Liabilities
34.10M	30.17M	21.88M	22.33M	21.19M	20.00M
	Stockholders Equity
24.65M	25.18B	22.62M	21.63M	24.24M	19.27M
Cash Flow		Free Cash Flow
-6.24M	-7.77M	-555.00K	6.85M	4.59M	9.29M
	Operating Cash Flow
4.54M	167.00K	5.72M	7.24M	6.27M	9.74M
	Investing Cash Flow
-9.94M	-7.07M	-6.27M	-388.00K	-1.67M	-2.39M
	Financing Cash Flow
3.85M	4.41M	1.91M	-2.66M	-655.00K	-4.81M

American Shared Hospital Services Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2.39
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AMS, the sentiment is Negative. The current price of 2.39 is below the 20-day moving average (MA) of 2.71, below the 50-day MA of 2.76, and below the 200-day MA of 3.02, indicating a bearish trend. The MACD of -0.07 indicates Positive momentum. The RSI at 34.55 is Neutral, neither overbought nor oversold. The STOCH value of 1.08 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AMS.

American Shared Hospital Services Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AMS	63 Neutral	$15.48M	10.85	6.16%	―	35.25%	175.21%
Sector *	53 Neutral	$5.24B	3.07	-43.58%	2.80%	16.87%	-0.11%
IXHL	39 Underperform	$7.06M	―	-201.88%	―	―	―
GOVX	34 Underperform	$15.80M	―	-616.17%	―	―	71.39%
MODV	33 Underperform	$13.76M	―	-951.52%	―	-0.70%	-2.38%
SCNX	27 Underperform	$12.45M	―	-30.97%	―	-97.79%	86.73%
MGRX		$17.43M	―	-115.87%	―	―	―

American Shared Hospital Services Corporate Events

American Shared Hospital Services Appoints New CEO

On April 3, 2025, American Shared Hospital Services announced the appointment of Gary Delanois as the new Chief Executive Officer, succeeding Raymond Stachowiak, who will remain as Executive Chairman. The company reported strong financial results for 2024, with a 32.9% increase in revenue driven by strategic expansion and operational strength. The acquisition of radiation therapy centers and new facility openings have been pivotal in this growth. The company is transitioning from a leasing model to a direct provider of radiation therapy services, aiming for sustainable long-term growth through increased patient volumes and operational enhancements.